Related Experiment Video
Updated: May 4, 2026

The Application of Open Searching-based Approaches for the Identification of Acinetobacter baumannii O-linked Glycopeptides
Published on: November 2, 2021
Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections
S Tevell1, C Claesson, B Hellmark
1Department of Infectious Diseases, Karlstad Hospital, Karlstad, Sweden, staffan.tevell@liv.se.
Abstract:
Methicillin-resistant Staphylococcus epidermidis (MRSE) poses a major problem in prosthetic joint infections (PJIs). Vancomycin is often considered the drug of choice in the empirical treatment of staphylococcal PJIs. As recent decades have seen reports of heterogeneous glycopeptide intermediate S. aureus (hGISA), our aim was to examine the prevalence of heterogeneous glycopeptide intermediate S. epidermidis (hGISE) in PJIs. S. epidermidis isolates (n = 122) from 119 patients in three Swedish counties between 1993 and 2012 were included. All were isolated from perioperative tissue samples from revision surgery in clinically verified PJIs. Antimicrobial susceptibility testing against staphylococcal antibiotics was performed. The macromethod Etest (MME) and glycopeptide resistance detection (GRD) Etest were used to detect hGISE. Standard minimal inhibitory concentration (MIC) determination revealed no vancomycin-resistant isolates, while teicoplanin resistance was detected in 14 out of 122 isolates (11.5%). hGISE was found in 95 out of 122 isolates (77.9%), 64 out of 67 of isolates with teicoplanin MIC >2 mg/L (95.5%) and 31 out of 55 of isolates with teicoplanin MIC ≤2 mg/L (56.4%). Thus, the presence of hGISE cannot be ruled out by teicoplanin MIC ≤2 mg/L alone. Multidrug resistance was detected in 86 out of 95 hGISE isolates (90.5%) and in 16 out of 27 isolates (59.3%), where hGISE could not be detected. In conclusion, hGISE detected by MME or GRD was common in this material. However, hGISE is difficult to detect with standard laboratory diagnostic routines. Glycopeptide treatment may not be sufficient in many of these PJIs, even if standard MIC classifies the isolated S. epidermidis as susceptible.
Insights
Heterogeneous vancomycin-intermediate Staphylococcus epidermidis (hGISE) is common in prosthetic joint infections (PJIs). Standard susceptibility testing may not detect hGISE, potentially leading to insufficient glycopeptide treatment for MRSE infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Diagnostics
Background:
- Methicillin-resistant Staphylococcus epidermidis (MRSE) is a significant pathogen in prosthetic joint infections (PJIs).
- Vancomycin is a primary antibiotic choice for empirical treatment of staphylococcal PJIs.
- Emerging reports of heterogeneous glycopeptide intermediate Staphylococcus aureus (hGISA) necessitate investigation into similar resistance mechanisms in S. epidermidis.
Purpose of the Study:
- To determine the prevalence of heterogeneous glycopeptide intermediate Staphylococcus epidermidis (hGISE) in PJIs.
- To evaluate the effectiveness of standard antimicrobial susceptibility testing in detecting hGISE.
- To assess the implications of hGISE on glycopeptide treatment efficacy in PJIs.
Main Methods:
- Analysis of 122 S. epidermidis isolates from 119 patients undergoing revision surgery for PJIs in Sweden (1993-2012).
- Antimicrobial susceptibility testing against various antibiotics, including vancomycin and teicoplanin.
- Detection of hGISE using the macromethod Etest (MME) and glycopeptide resistance detection (GRD) Etest.
Main Results:
- No vancomycin-resistant S. epidermidis isolates were found; however, 11.5% exhibited teicoplanin resistance.
- hGISE was prevalent, detected in 77.9% of isolates.
- hGISE was identified even in isolates with teicoplanin Minimum Inhibitory Concentration (MIC) ≤2 mg/L, indicating limitations of standard MIC testing.
- Multidrug resistance was significantly higher in hGISE-positive isolates (90.5%) compared to hGISE-negative isolates (59.3%).
Conclusions:
- Heterogeneous glycopeptide intermediate S. epidermidis (hGISE) is a common finding in prosthetic joint infections.
- Standard laboratory diagnostic methods may fail to detect hGISE, complicating treatment decisions.
- Glycopeptide therapy may be inadequate for PJIs caused by hGISE-positive S. epidermidis, even when standard susceptibility tests indicate susceptibility.
Related Concept Videos
Staphylococcal Skin Infections
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Peptidoglycan Synthesis
Microbiome of the Eye

